Hendrik Peter Scholl - 18 Jun 2026 Form 4 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship: Chief Medical Officer
Issuer ticker: BLTE
Reported as of: 18 Jun 2026
Net transaction value: -$1,452,435
SEC form: 4
Accepted by SEC: 22 Jun 2026, 06:05:45 UTC
Prior SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Hendrik Peter Scholl

Key filing fact

Hendrik Peter Scholl filed Form 4 for BELITE BIO, INC (BLTE) on 22 Jun 2026.

Key facts

This page summarizes Hendrik Peter Scholl's Form 4 filing for BELITE BIO, INC (BLTE).
5 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 06:05.

Change

Previous filing in this sequence was filed on 17 Jun 2026.
Current net transaction value: -$1,452,435.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002113223 Primary reporting owner

Scholl Hendrik Peter

Relationship: Chief Medical Officer
Address: GOTTHARDSTRASSE 26, ZUG, SWITZERLAND
Signature: /s/ Hendrik Peter Scholl
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE transaction

American depositary share

Sale

Transaction value: $13,814
Shares: -96
Change %: -0.38%
Price: $143.90
Shares after: 24,904
Date: 18 Jun 2026
Ownership: By Bioptima Ltd.
Footnotes: F1

BLTE transaction

American depositary share

Sale

Transaction value: $542,192
Shares: -3,748
Change %: -15%
Price: $144.66
Shares after: 21,156
Date: 18 Jun 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2

BLTE transaction

American depositary share

Sale

Transaction value: $706,959
Shares: -4,861
Change %: -23%
Price: $145.43
Shares after: 16,295
Date: 18 Jun 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F3

BLTE transaction

American depositary share

Sale

Transaction value: $175,348
Shares: -1,199
Change %: -7.4%
Price: $146.24
Shares after: 15,096
Date: 18 Jun 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F4

BLTE transaction

American depositary share

Sale

Transaction value: $14,123
Shares: -96
Change %: -0.64%
Price: $147.11
Shares after: 15,000
Date: 18 Jun 2026
Ownership: By Bioptima Ltd.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.

Footnote F2

Represents the weighted average price of shares sold at prices that ranged from $144.07 to $144.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F3

Represents the weighted average price of shares sold at prices that ranged from $145 to $145.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F4

Represents the weighted average price of shares sold at prices that ranged from $146.005 to $146.755. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.